Suppr超能文献

择期癌症手术后的术中吸入氧分数与无复发生存率相关。

Intraoperative Fractions of Inspiratory Oxygen Are Associated With Recurrence-Free Survival After Elective Cancer Surgery.

作者信息

Dehne Sarah, Spang Verena, Klotz Rosa, Kummer Laura, Kilian Samuel, Hoffmann Katrin, Schneider Martin A, Hackert Thilo, Büchler Markus W, Weigand Markus A, Larmann Jan

机构信息

Department of Anesthesiology, University Hospital Heidelberg, Heidelberg, Germany.

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

Front Med (Lausanne). 2021 Nov 26;8:761786. doi: 10.3389/fmed.2021.761786. eCollection 2021.

Abstract

Choice of the fraction of inspiratory oxygen (FiO) is controversial. The objective of this analysis was to evaluate whether intraoperative FiO was associated with recurrence-free survival after elective cancer surgery. In this single-center, retrospective study, we analyzed 1,084 patients undergoing elective resection of pancreatic ( = 652), colorectal ( = 405), or hepatic cancer ( = 27) at Heidelberg University Hospital between 2009 and 2016. Intraoperative mean FiO values were calculated. For unstratified analyses, the study cohort was equally divided into a low- and a high-FiO group. For cancer-stratified analyses, this division was done within cancer-strata. The primary outcome measure was recurrence-free survival until the last known follow-up. Groups were compared using Kaplan-Meier analysis. A stratified log rank test was used to control for different FiO levels and survival times between the cancer strata. Cox-regression analyses were used to control for covariates. Sepsis, reoperations, surgical-site infections, and cardiovascular events during hospital stay and overall survival were secondary outcomes. Median FiO was 40.9% (Q1-Q3, 38.3-42.9) in the low vs. 50.4% (Q1-Q3, 47.4-54.7) in the high-FiO group. Median follow-up was 3.28 (Q1-Q3, 1.68-4.97) years. Recurrence-free survival was considerable higher in the high-FiO group ( < 0.001). This effect was also confirmed when stratified for the different tumor entities ( = 0.007). In colorectal cancer surgery, increased FiO was independently associated with increased recurrence-free survival. The hazard for the primary outcome decreased by 3.5% with every 1% increase in FiO. The effect was not seen in pancreatic cancer surgery and we did not find differences in any of the secondary endpoints. Until definite evidence from large-scale trials is available and in the absence of relevant clinical conditions warranting specific FiO values, perioperative care givers should aim for an intraoperative FiO of 50% in abdominal cancer surgery as this might benefit oncological outcomes.

摘要

吸入氧分数(FiO₂)的选择存在争议。本分析的目的是评估择期癌症手术后术中FiO₂是否与无复发生存期相关。在这项单中心回顾性研究中,我们分析了2009年至2016年间在海德堡大学医院接受胰腺(n = 652)、结直肠(n = 405)或肝癌(n = 27)择期切除的1084例患者。计算术中平均FiO₂值。在非分层分析中,研究队列被等分为低FiO₂组和高FiO₂组。在癌症分层分析中,这种划分在癌症层内进行。主要结局指标是直至最后一次已知随访的无复发生存期。使用Kaplan-Meier分析对组进行比较。采用分层对数秩检验来控制癌症层之间不同的FiO₂水平和生存时间。使用Cox回归分析来控制协变量。住院期间的脓毒症、再次手术率、手术部位感染和心血管事件以及总生存是次要结局。低FiO₂组的FiO₂中位数为40.9%(四分位间距,38.3 - 42.9),而高FiO₂组为50.4%(四分位间距,47.4 - 54.7)。中位随访时间为3.28(四分位间距,1.68 - 4.97)年。高FiO₂组的无复发生存期显著更高(P < 0.001)。当按不同肿瘤实体分层时,这种效应也得到了证实(P = 0.007)。在结直肠癌手术中,FiO₂升高与无复发生存期增加独立相关。FiO₂每增加1%,主要结局的风险降低3.5%。在胰腺癌手术中未观察到这种效应,并且我们在任何次要终点中均未发现差异。在有来自大规模试验的确切证据之前,并且在没有需要特定FiO₂值的相关临床情况时,围手术期护理人员在腹部癌症手术中应将术中FiO₂目标设定为50%,因为这可能有益于肿瘤学结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a1a/8661123/310399ea75ad/fmed-08-761786-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验